Try our Advanced Search for more refined results

Expert Analysis

CBD Scrutiny May Signal Broader FDA Enforcement Trend

By Lauren Farruggia, Megan Robertson, Gail Javitt, Brian Hedgeman and Jack Wenik ( April 9, 2019, 12:47 PM EDT) -- On April 2, 2019, the U.S. Food and Drug Administration issued a statement by FDA Commissioner Scott Gottlieb announcing the agency's latest enforcement actions taken against companies allegedly engaging in unlawful marketing of cannabidiol, or CBD products.[1] Coming just days before Gottlieb's departure from the agency, this news otherwise is unsurprising given recent CBD legislative and enforcement initiatives at the federal and state level....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!